(-)-epigallocatechin 3-gallate increases expression ISO RGD:735683 6480464 epigallocatechin gallate results in increased expression of SLC31A1 mRNA, epigallocatechin gallate results in increased expression of SLC31A1 protein CTD PMID:25927922 , PMID:27270317 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735683 6480464 epigallocatechin gallate inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein], epigallocatechin gallate results in increased expression of and affects the localization of SLC31A1 protein CTD PMID:25927922 , PMID:27270317 (1->4)-beta-D-glucan multiple interactions ISO RGD:735684 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC31A1 mRNA CTD PMID:36331819 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:735683 6480464 o, p'-DDT results in increased expression of SLC31A1 mRNA CTD PMID:19371625 1,2-dimethylhydrazine multiple interactions ISO RGD:735684 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC31A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:735684 6480464 Ethinyl Estradiol affects the expression of SLC31A1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO RGD:735684 6480464 Ethinyl Estradiol results in decreased expression of SLC31A1 mRNA, Ethinyl Estradiol results in decreased expression of SLC31A1 protein CTD PMID:27690074 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC31A1 mRNA CTD PMID:26865667 17alpha-ethynylestradiol multiple interactions ISO RGD:735684 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC31A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:735684 6480464 Ethinyl Estradiol results in increased expression of SLC31A1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:735683 6480464 Estradiol inhibits the reaction [Copper results in decreased expression of SLC31A1 protein], Estradiol promotes the reaction [Copper affects the expression of SLC31A1 mRNA] CTD PMID:19685012 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC31A1 mRNA CTD PMID:26496021 17beta-estradiol increases expression ISO RGD:735683 6480464 Estradiol results in increased expression of SLC31A1 mRNA CTD PMID:19685012 17beta-estradiol 3-benzoate decreases expression EXP 6480464 estradiol 3-benzoate results in decreased expression of SLC31A1 mRNA CTD PMID:32741896 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:735683 6480464 Metribolone results in increased expression of SLC31A1 mRNA, Metribolone results in increased expression of SLC31A1 protein CTD PMID:25320179 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:735683 6480464 [Metribolone results in increased expression of SLC31A1 protein] which results in increased import of Copper more ... CTD PMID:25320179 2,2,2-tetramine increases expression EXP 6480464 Trientine results in increased expression of SLC31A1 mRNA CTD PMID:22362149 2,2,2-tetramine increases expression ISO RGD:735683 6480464 Trientine results in increased expression of SLC31A1 mRNA, Trientine results in increased expression of SLC31A1 protein CTD PMID:22914438 2,2,2-tetramine multiple interactions ISO RGD:735683 6480464 [Trientine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to oxaliplatin more ... CTD PMID:22491798 , PMID:22914438 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:735684 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC31A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:735684 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC31A1 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735683 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC31A1 mRNA CTD PMID:26238291 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735684 6480464 Tetrachlorodibenzodioxin affects the expression of SLC31A1 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO RGD:735683 6480464 Lactic Acid results in decreased expression of SLC31A1 mRNA CTD PMID:30851411 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:735684 6480464 3 more ... CTD PMID:19467301 3-Iodothyronamine affects uptake ISO RGD:735683 6480464 SLC31A1 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of SLC31A1 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases methylation ISO RGD:735684 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SLC31A1 exon CTD PMID:33297965 5-aza-2'-deoxycytidine increases expression ISO RGD:735683 6480464 Decitabine results in increased expression of SLC31A1 protein CTD PMID:19470736 aflatoxin B1 affects expression ISO RGD:735683 6480464 Aflatoxin B1 affects the expression of SLC31A1 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:735683 6480464 Aflatoxin B1 results in decreased methylation of SLC31A1 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:735683 6480464 Aflatoxin B1 results in decreased expression of SLC31A1 mRNA CTD PMID:22100608 aflatoxin B1 decreases expression ISO RGD:735684 6480464 Aflatoxin B1 results in decreased expression of SLC31A1 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO RGD:735683 6480464 Tretinoin results in increased expression of SLC31A1 mRNA CTD PMID:23724009 amiloride multiple interactions ISO RGD:735683 6480464 Amiloride inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC31A1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:735683 6480464 Antirheumatic Agents results in decreased expression of SLC31A1 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:735684 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of SLC31A1 mRNA CTD PMID:23650126 bathocuproine disulfonic acid multiple interactions ISO RGD:735683 6480464 [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA, bathocuproine sulfonate promotes the reaction [SP1 protein results in increased expression of SLC31A1 mRNA] CTD PMID:18483225 benzo[a]pyrene increases expression ISO RGD:735684 6480464 Benzo(a)pyrene results in increased expression of SLC31A1 mRNA CTD PMID:21569818 , PMID:27195522 benzo[a]pyrene decreases methylation ISO RGD:735683 6480464 Benzo(a)pyrene results in decreased methylation of SLC31A1 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:735683 6480464 Benzo(a)pyrene results in decreased expression of SLC31A1 mRNA CTD PMID:26238291 , PMID:32234424 benzo[a]pyrene decreases expression ISO RGD:735684 6480464 Benzo(a)pyrene results in decreased expression of SLC31A1 mRNA CTD PMID:22228805 bisphenol A increases expression ISO RGD:735683 6480464 bisphenol A results in increased expression of SLC31A1 mRNA CTD PMID:19371625 bisphenol A decreases expression ISO RGD:735684 6480464 bisphenol A results in decreased expression of SLC31A1 mRNA, bisphenol A results in decreased expression of SLC31A1 protein CTD PMID:27690074 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC31A1 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of SLC31A1 mRNA CTD PMID:26496021 bortezomib multiple interactions ISO RGD:735683 6480464 [Bortezomib inhibits the reaction [Cisplatin results in decreased expression of SLC31A1 protein]] which results in increased uptake of Cisplatin more ... CTD PMID:19147760 , PMID:24209693 bortezomib decreases degradation ISO RGD:735683 6480464 Bortezomib results in decreased degradation of SLC31A1 protein CTD PMID:24209693 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SLC31A1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO RGD:735683 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC31A1 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:735683 6480464 Cadmium Chloride results in increased expression of SLC31A1 mRNA CTD PMID:26472689 cadmium dichloride multiple interactions ISO RGD:735683 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC31A1 mRNA CTD PMID:35301059 carboplatin decreases response to substance ISO RGD:735684 6480464 SLC31A1 gene mutant form results in decreased susceptibility to Carboplatin CTD PMID:16847145 carboplatin multiple interactions ISO RGD:735683 6480464 [Penicillamine results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Carboplatin more ... CTD PMID:22914438 carboplatin increases import EXP 6480464 SLC31A1 protein results in increased import of Carboplatin CTD PMID:23123662 carboplatin increases uptake ISO RGD:735684 6480464 SLC31A1 protein results in increased uptake of Carboplatin CTD PMID:16847145 , PMID:19509135 carboplatin increases uptake ISO RGD:735683 6480464 SLC31A1 protein results in increased uptake of Carboplatin CTD PMID:15634647 carboplatin increases response to substance ISO RGD:735683 6480464 SLC31A1 protein results in increased susceptibility to Carboplatin CTD PMID:15634647 casticin increases expression ISO RGD:735684 6480464 casticin results in increased expression of SLC31A1 mRNA CTD PMID:28444820 celecoxib multiple interactions ISO RGD:735683 6480464 [Celecoxib results in decreased expression of SLC31A1 protein] which results in decreased import of and results in decreased susceptibility to Cisplatin CTD PMID:21177414 celecoxib decreases expression ISO RGD:735683 6480464 Celecoxib results in decreased expression of SLC31A1 protein CTD PMID:21177414 celecoxib affects expression ISO RGD:735684 6480464 Celecoxib affects the expression of SLC31A1 mRNA CTD PMID:20562220 chlorpromazine multiple interactions ISO RGD:735683 6480464 Chlorpromazine inhibits the reaction [Copper affects the localization of SLC31A1 protein] CTD PMID:12501239 chromium(6+) affects expression ISO RGD:735684 6480464 chromium hexavalent ion affects the expression of SLC31A1 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO RGD:735683 6480464 [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in decreased expression of SLC31A1 protein] which results in decreased import of and results in decreased susceptibility to Cisplatin more ... CTD PMID:17108132 more ... cisplatin decreases expression ISO RGD:735684 6480464 Cisplatin results in decreased expression of SLC31A1 mRNA CTD PMID:31493026 cisplatin increases expression ISO RGD:735683 6480464 [Cisplatin results in increased expression of SP1 protein] which results in increased expression of SLC31A1 mRNA more ... CTD PMID:22914438 , PMID:24132751 cisplatin increases import ISO RGD:735683 6480464 SLC31A1 protein results in increased import of Cisplatin CTD PMID:24132751 cisplatin increases import EXP 6480464 SLC31A1 protein results in increased import of Cisplatin CTD PMID:23123662 cisplatin decreases response to substance ISO RGD:735683 6480464 SLC31A1 protein results in decreased susceptibility to Cisplatin CTD PMID:24800945 cisplatin decreases expression ISO RGD:735683 6480464 Cisplatin results in decreased expression of SLC31A1 protein CTD PMID:19147760 , PMID:24800945 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SLC31A1 mRNA CTD PMID:26739623 cisplatin increases degradation ISO RGD:735683 6480464 Cisplatin results in increased degradation of SLC31A1 protein CTD PMID:17108132 more ... cisplatin increases uptake ISO RGD:735684 6480464 SLC31A1 protein results in increased uptake of Cisplatin CTD PMID:16847145 more ... cisplatin increases response to substance EXP 6480464 SLC31A1 protein results in increased susceptibility to Cisplatin CTD PMID:19144690 cisplatin increases transport ISO RGD:735683 6480464 SLC31A1 protein results in increased transport of Cisplatin CTD PMID:19570948 cisplatin affects response to substance ISO RGD:735683 6480464 SLC31A1 mRNA affects the susceptibility to Cisplatin, SLC31A1 protein affects the susceptibility to Cisplatin CTD PMID:18610736 , PMID:22914438 cisplatin increases response to substance ISO RGD:735683 6480464 SLC31A1 protein mutant form results in increased susceptibility to Cisplatin, SLC31A1 protein results in increased susceptibility to Cisplatin CTD PMID:15634647 more ... cisplatin increases uptake ISO RGD:735683 6480464 SLC31A1 protein mutant form results in increased uptake of Cisplatin, SLC31A1 protein results in increased uptake of Cisplatin CTD PMID:15634647 more ... cisplatin decreases response to substance ISO RGD:735684 6480464 SLC31A1 gene mutant form results in decreased susceptibility to Cisplatin CTD PMID:16847145 cisplatin multiple interactions ISO RGD:735684 6480464 [Copper Sulfate results in decreased activity of SLC31A1 protein] which results in decreased uptake of Cisplatin, SLC31A1 gene mutant form results in decreased uptake of and results in decreased susceptibility to Cisplatin CTD PMID:16170571 , PMID:20631178 cisplatin affects uptake ISO RGD:735683 6480464 SLC31A1 protein affects the uptake of Cisplatin CTD PMID:15985617 , PMID:27270317 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC31A1 mRNA CTD PMID:17602206 cobalt dichloride multiple interactions ISO RGD:735683 6480464 SLC31A1 mutant form inhibits the reaction [cobaltous chloride results in decreased expression of CDH1 protein], SLC31A1 mutant form inhibits the reaction [cobaltous chloride results in increased expression of VIM mRNA] CTD PMID:26174737 cobalt dichloride increases expression ISO RGD:735683 6480464 cobaltous chloride results in increased expression of SLC31A1 mRNA CTD PMID:24614111 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:15591161 more ... copper atom increases uptake ISO RGD:735683 6480464 SLC31A1 protein mutant form results in increased uptake of Copper, SLC31A1 protein results in increased uptake of Copper CTD PMID:12177073 more ... copper atom affects localization ISO RGD:735683 6480464 Copper affects the localization of SLC31A1 protein CTD PMID:12501239 more ... copper atom increases import ISO RGD:735683 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23426973 more ... copper atom increases import EXP 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23123662 copper atom decreases abundance ISO RGD:735684 6480464 SLC31A1 protein modified form results in decreased abundance of Copper CTD PMID:24167251 copper atom increases abundance ISO RGD:735684 6480464 SLC31A1 protein results in increased abundance of Copper CTD PMID:24522273 copper atom increases uptake EXP 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:24316150 copper atom increases transport EXP 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:22465424 copper atom increases uptake ISO RGD:735684 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:11391004 more ... copper atom affects uptake ISO RGD:735683 6480464 SLC31A1 protein affects the uptake of Copper CTD PMID:12872841 copper atom increases transport ISO RGD:735683 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:12220667 more ... copper atom increases degradation ISO RGD:735683 6480464 Copper results in increased degradation of SLC31A1 protein CTD PMID:12501239 , PMID:17108132 copper atom affects abundance ISO RGD:735684 6480464 SLC31A1 gene mutant form affects the abundance of Copper CTD PMID:12177073 copper atom decreases expression ISO RGD:735683 6480464 Copper results in decreased expression of SLC31A1 mRNA, Copper results in decreased expression of SLC31A1 protein CTD PMID:18483225 more ... copper atom increases expression ISO RGD:735683 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:18483225 more ... copper atom multiple interactions ISO RGD:735683 6480464 [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA more ... CTD PMID:12501239 more ... copper atom decreases response to substance ISO RGD:735683 6480464 SLC31A1 protein mutant form results in decreased susceptibility to Copper CTD PMID:20519567 copper atom decreases uptake ISO RGD:735683 6480464 SLC31A1 mutant form results in decreased uptake of Copper CTD PMID:23543413 copper atom decreases transport ISO RGD:735683 6480464 SLC31A1 protein mutant form results in decreased transport of Copper CTD PMID:20519567 copper atom multiple interactions ISO RGD:735684 6480464 [ATP7B gene mutant form results in decreased export of Copper] which results in decreased expression of SLC31A1 protein more ... CTD PMID:12177073 more ... copper atom affects transport ISO RGD:735684 6480464 SLC31A1 protein affects the transport of Copper CTD PMID:17268249 copper atom increases secretion EXP 6480464 SLC31A1 protein results in increased secretion of Copper CTD PMID:16741141 copper atom multiple interactions EXP 6480464 Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] more ... CTD PMID:16741141 more ... copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:15591161 more ... copper(0) increases uptake ISO RGD:735683 6480464 SLC31A1 protein mutant form results in increased uptake of Copper, SLC31A1 protein results in increased uptake of Copper CTD PMID:12177073 more ... copper(0) affects localization ISO RGD:735683 6480464 Copper affects the localization of SLC31A1 protein CTD PMID:12501239 more ... copper(0) increases import ISO RGD:735683 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23426973 more ... copper(0) increases import EXP 6480464 SLC31A1 protein results in increased import of Copper CTD PMID:23123662 copper(0) decreases abundance ISO RGD:735684 6480464 SLC31A1 protein modified form results in decreased abundance of Copper CTD PMID:24167251 copper(0) increases abundance ISO RGD:735684 6480464 SLC31A1 protein results in increased abundance of Copper CTD PMID:24522273 copper(0) increases uptake EXP 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:24316150 copper(0) increases transport EXP 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:22465424 copper(0) increases uptake ISO RGD:735684 6480464 SLC31A1 protein results in increased uptake of Copper CTD PMID:11391004 more ... copper(0) affects uptake ISO RGD:735683 6480464 SLC31A1 protein affects the uptake of Copper CTD PMID:12872841 copper(0) increases transport ISO RGD:735683 6480464 SLC31A1 protein results in increased transport of Copper CTD PMID:12220667 more ... copper(0) increases degradation ISO RGD:735683 6480464 Copper results in increased degradation of SLC31A1 protein CTD PMID:12501239 , PMID:17108132 copper(0) affects abundance ISO RGD:735684 6480464 SLC31A1 gene mutant form affects the abundance of Copper CTD PMID:12177073 copper(0) decreases expression ISO RGD:735683 6480464 Copper results in decreased expression of SLC31A1 mRNA, Copper results in decreased expression of SLC31A1 protein CTD PMID:18483225 more ... copper(0) increases expression ISO RGD:735683 6480464 Copper deficiency results in increased expression of SLC31A1 mRNA more ... CTD PMID:18483225 more ... copper(0) multiple interactions ISO RGD:735683 6480464 [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA more ... CTD PMID:12501239 more ... copper(0) decreases transport ISO RGD:735683 6480464 SLC31A1 protein mutant form results in decreased transport of Copper CTD PMID:20519567 copper(0) decreases uptake ISO RGD:735683 6480464 SLC31A1 mutant form results in decreased uptake of Copper CTD PMID:23543413 copper(0) decreases response to substance ISO RGD:735683 6480464 SLC31A1 protein mutant form results in decreased susceptibility to Copper CTD PMID:20519567 copper(0) multiple interactions ISO RGD:735684 6480464 [ATP7B gene mutant form results in decreased export of Copper] which results in decreased expression of SLC31A1 protein more ... CTD PMID:12177073 more ... copper(0) affects transport ISO RGD:735684 6480464 SLC31A1 protein affects the transport of Copper CTD PMID:17268249 copper(0) increases secretion EXP 6480464 SLC31A1 protein results in increased secretion of Copper CTD PMID:16741141 copper(0) multiple interactions EXP 6480464 Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] more ... CTD PMID:16741141 more ... copper(II) chloride decreases expression EXP 6480464 cupric chloride results in decreased expression of SLC31A1 protein CTD PMID:24316150 copper(II) chloride multiple interactions ISO RGD:735683 6480464 SLC31A1 protein results in increased susceptibility to [cupric chloride results in increased abundance of Copper] CTD PMID:32278528 copper(II) chloride decreases expression ISO RGD:735683 6480464 cupric chloride results in decreased expression of SLC31A1 protein CTD PMID:24800945 copper(II) sulfate multiple interactions ISO RGD:735684 6480464 [Copper Sulfate results in decreased activity of SLC31A1 protein] which results in decreased uptake of Cisplatin more ... CTD PMID:20631178 , PMID:22842628 copper(II) sulfate decreases expression ISO RGD:735683 6480464 [Copper Sulfate results in decreased expression of SP1 mRNA] which results in decreased expression of SLC31A1 mRNA, Copper Sulfate results in decreased expression of SLC31A1 mRNA CTD PMID:19549813 more ... copper(II) sulfate multiple interactions ISO RGD:735683 6480464 Copper Sulfate inhibits the reaction [Cisplatin results in increased expression of SLC31A1 mRNA] more ... CTD PMID:22172574 , PMID:24132751 copper(II) sulfate decreases activity ISO RGD:735684 6480464 Copper Sulfate results in decreased activity of SLC31A1 protein CTD PMID:20631178 coumestrol increases expression ISO RGD:735683 6480464 Coumestrol results in increased expression of SLC31A1 mRNA CTD PMID:19167446 CU-O LINKAGE increases expression ISO RGD:735683 6480464 cupric oxide analog results in increased expression of SLC31A1 mRNA, cupric oxide analog results in increased expression of SLC31A1 protein CTD PMID:24815816 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of SLC31A1 mRNA CTD PMID:27523638 cytochalasin D multiple interactions ISO RGD:735683 6480464 Cytochalasin D inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 D-penicillamine multiple interactions ISO RGD:735683 6480464 [Penicillamine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to Oxaliplatin more ... CTD PMID:22914438 D-penicillamine increases expression ISO RGD:735683 6480464 Penicillamine results in increased expression of SLC31A1 mRNA CTD PMID:22914438 diazinon increases methylation ISO RGD:735683 6480464 Diazinon results in increased methylation of SLC31A1 gene CTD PMID:22964155 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC31A1 mRNA CTD PMID:21658437 dioxygen multiple interactions ISO RGD:735684 6480464 [Oxygen deficiency results in increased expression of SLC31A1 protein] which results in increased uptake of Copper CTD PMID:19351718 dioxygen multiple interactions ISO RGD:735683 6480464 HIF1A mRNA promotes the reaction [Oxygen deficiency results in increased expression of SLC31A1 mRNA] CTD PMID:24614111 dioxygen increases expression ISO RGD:735683 6480464 Oxygen deficiency results in increased expression of SLC31A1 mRNA CTD PMID:24614111 dioxygen increases expression ISO RGD:735684 6480464 Oxygen deficiency results in increased expression of SLC31A1 mRNA, Oxygen deficiency results in increased expression of SLC31A1 protein CTD PMID:19351718 , PMID:24614111 diuron increases expression EXP 6480464 Diuron results in increased expression of SLC31A1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:735683 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A1 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:735683 6480464 Ethyl Methanesulfonate results in decreased expression of SLC31A1 mRNA CTD PMID:23649840 folic acid multiple interactions ISO RGD:735684 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC31A1 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:735683 6480464 Formaldehyde results in decreased expression of SLC31A1 mRNA CTD PMID:23649840 fructose multiple interactions EXP 6480464 Fructose inhibits the reaction [Copper deficiency results in increased expression of SLC31A1 protein] CTD PMID:21781943 fumonisin B1 decreases expression ISO RGD:735684 6480464 fumonisin B1 results in decreased expression of SLC31A1 mRNA CTD PMID:16221962 genistein increases expression ISO RGD:735683 6480464 Genistein results in increased expression of SLC31A1 mRNA CTD PMID:19371625 , PMID:26865667 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC31A1 mRNA CTD PMID:33387578 glutathione multiple interactions ISO RGD:735683 6480464 [Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23426973 graphite affects expression EXP 6480464 Graphite affects the expression of SLC31A1 mRNA CTD PMID:29933104 hydrogen peroxide multiple interactions ISO RGD:735684 6480464 Hydrogen Peroxide inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]], Hydrogen Peroxide inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] CTD PMID:22842628 irinotecan affects expression EXP 6480464 Irinotecan affects the expression of SLC31A1 mRNA CTD PMID:20097248 isotretinoin decreases expression ISO RGD:735683 6480464 Isotretinoin results in decreased expression of SLC31A1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO RGD:735683 6480464 Ivermectin results in decreased expression of SLC31A1 protein CTD PMID:32959892 lactacystin multiple interactions ISO RGD:735683 6480464 lactacystin inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 lamivudine multiple interactions ISO RGD:735683 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA CTD PMID:15784690 lead diacetate multiple interactions EXP 6480464 lead acetate promotes the reaction [SLC31A1 protein results in increased uptake of Copper], lead acetate results in increased expression of and affects the localization of SLC31A1 protein CTD PMID:24316150 , PMID:25579025 lead diacetate increases expression ISO RGD:735684 6480464 lead acetate results in increased expression of SLC31A1 mRNA, lead acetate results in increased expression of SLC31A1 protein CTD PMID:30623991 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC31A1 mRNA, lead acetate results in increased expression of SLC31A1 protein CTD PMID:24316150 , PMID:25579025 lead(0) multiple interactions EXP 6480464 SLC31A1 mutant form inhibits the reaction [Lead results in decreased export of Copper] CTD PMID:24316150 lipopolysaccharide increases expression ISO RGD:735684 6480464 Lipopolysaccharides results in increased expression of SLC31A1 mRNA CTD PMID:22369063 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of SLC31A1 mRNA CTD PMID:26739623 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SLC31A1 mRNA CTD PMID:28801915 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC31A1 mRNA CTD PMID:30467583 methyl beta-cyclodextrin multiple interactions ISO RGD:735683 6480464 methyl-beta-cyclodextrin inhibits the reaction [Copper affects the localization of SLC31A1 protein] CTD PMID:12501239 methyl methanesulfonate decreases expression ISO RGD:735683 6480464 Methyl Methanesulfonate results in decreased expression of SLC31A1 mRNA CTD PMID:23649840 Methylazoxymethanol acetate increases expression EXP 6480464 Methylazoxymethanol Acetate results in increased expression of SLC31A1 mRNA CTD PMID:28349193 methylmercury chloride increases expression ISO RGD:735683 6480464 methylmercuric chloride results in increased expression of SLC31A1 mRNA CTD PMID:28001369 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:735683 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Cisplatin results in increased degradation of SLC31A1 protein] CTD PMID:17108132 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC31A1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SLC31A1 mRNA CTD PMID:17602206 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of SLC31A1 mRNA, nitrofen results in decreased expression of SLC31A1 protein CTD PMID:25319798 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC31A1 protein CTD PMID:20836889 oxaliplatin multiple interactions EXP 6480464 copper histidine inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin], Copper inhibits the reaction [SLC31A1 protein results in increased import of oxaliplatin] CTD PMID:23123662 , PMID:23556474 oxaliplatin increases uptake ISO RGD:735684 6480464 SLC31A1 protein results in increased uptake of oxaliplatin CTD PMID:16847145 oxaliplatin decreases response to substance ISO RGD:735684 6480464 SLC31A1 gene mutant form results in decreased susceptibility to oxaliplatin CTD PMID:16847145 oxaliplatin increases import EXP 6480464 SLC31A1 protein results in increased import of oxaliplatin CTD PMID:23123662 oxaliplatin affects response to substance ISO RGD:735683 6480464 SLC31A1 protein affects the susceptibility to oxaliplatin CTD PMID:16773204 oxaliplatin multiple interactions ISO RGD:735683 6480464 [Penicillamine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to oxaliplatin more ... CTD PMID:22914438 oxaliplatin increases response to substance ISO RGD:735683 6480464 SLC31A1 protein results in increased susceptibility to oxaliplatin CTD PMID:15634647 oxaliplatin increases uptake ISO RGD:735683 6480464 SLC31A1 protein results in increased uptake of oxaliplatin CTD PMID:15634647 paclitaxel increases expression ISO RGD:735683 6480464 Paclitaxel results in increased expression of SLC31A1 mRNA CTD PMID:20737486 paracetamol affects expression ISO RGD:735684 6480464 Acetaminophen affects the expression of SLC31A1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC31A1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:735683 6480464 Acetaminophen results in decreased expression of SLC31A1 mRNA CTD PMID:21420995 paraquat decreases response to substance ISO RGD:735683 6480464 SLC31A1 gene results in decreased susceptibility to Paraquat CTD PMID:29058724 paraquat increases expression ISO RGD:735683 6480464 Paraquat results in increased expression of SLC31A1 mRNA CTD PMID:34097952 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:735684 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC31A1 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SLC31A1 mRNA CTD PMID:36331819 phenylmercury acetate increases expression ISO RGD:735683 6480464 Phenylmercuric Acetate results in increased expression of SLC31A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735683 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A1 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:735684 6480464 pirinixic acid results in decreased expression of SLC31A1 mRNA CTD PMID:18445702 , PMID:23811191 platinum affects response to substance ISO RGD:735683 6480464 SLC31A1 affects the susceptibility to Platinum CTD PMID:21570711 platinum increases uptake ISO RGD:735683 6480464 SLC31A1 protein results in increased uptake of Platinum CTD PMID:22491798 platinum multiple interactions ISO RGD:735683 6480464 [Bortezomib results in decreased degradation of SLC31A1 protein] which results in increased uptake of Platinum, Trientine promotes the reaction [SLC31A1 protein results in increased uptake of Platinum] CTD PMID:22491798 , PMID:24209693 platinum(0) affects response to substance ISO RGD:735683 6480464 SLC31A1 affects the susceptibility to Platinum CTD PMID:21570711 platinum(0) multiple interactions ISO RGD:735683 6480464 [Bortezomib results in decreased degradation of SLC31A1 protein] which results in increased uptake of Platinum, Trientine promotes the reaction [SLC31A1 protein results in increased uptake of Platinum] CTD PMID:22491798 , PMID:24209693 platinum(0) increases uptake ISO RGD:735683 6480464 SLC31A1 protein results in increased uptake of Platinum CTD PMID:22491798 rac-lactic acid decreases expression ISO RGD:735683 6480464 Lactic Acid results in decreased expression of SLC31A1 mRNA CTD PMID:30851411 resveratrol increases expression ISO RGD:735683 6480464 resveratrol results in increased expression of SLC31A1 mRNA CTD PMID:19371625 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:735683 6480464 [Buthionine Sulfoximine results in decreased abundance of Glutathione] inhibits the reaction [SLC31A1 protein results in increased import of Copper] more ... CTD PMID:23426973 SB 431542 multiple interactions ISO RGD:735683 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC31A1 mRNA CTD PMID:27188386 silver atom multiple interactions EXP 6480464 Silver inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662 silver(0) multiple interactions EXP 6480464 Silver inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662 silver(1+) nitrate increases expression ISO RGD:735683 6480464 Silver Nitrate results in increased expression of SLC31A1 mRNA CTD PMID:24132751 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of SLC31A1 mRNA CTD PMID:22561333 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of SLC31A1 mRNA, Streptozocin results in decreased expression of SLC31A1 protein CTD PMID:24927960 tamoxifen affects expression ISO RGD:735684 6480464 Tamoxifen affects the expression of SLC31A1 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO RGD:735684 6480464 tert-Butylhydroperoxide results in decreased expression of SLC31A1 mRNA CTD PMID:14729362 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC31A1 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:735684 6480464 Carbon Tetrachloride results in decreased expression of SLC31A1 mRNA CTD PMID:31919559 tetrathiomolybdate(2-) multiple interactions ISO RGD:735683 6480464 [tetrathiomolybdate results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to oxaliplatin more ... CTD PMID:22172574 , PMID:22914438 tetrathiomolybdate(2-) increases expression ISO RGD:735683 6480464 tetrathiomolybdate results in increased expression of SLC31A1 mRNA CTD PMID:22914438 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC31A1 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:735684 6480464 titanium dioxide affects the expression of SLC31A1 mRNA CTD PMID:17656681 trichostatin A affects expression ISO RGD:735683 6480464 trichostatin A affects the expression of SLC31A1 mRNA CTD PMID:28542535 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of SLC31A1 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:735683 6480464 Valproic Acid results in decreased methylation of SLC31A1 gene CTD PMID:29154799 vanadium atom decreases expression ISO RGD:735683 6480464 Vanadium results in decreased expression of SLC31A1 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:735683 6480464 Vanadium results in decreased expression of SLC31A1 mRNA CTD PMID:19000753 Y-27632 decreases expression ISO RGD:735683 6480464 Y 27632 results in decreased expression of SLC31A1 mRNA CTD PMID:20878077 zearalenone increases expression ISO RGD:735683 6480464 Zearalenone results in increased expression of SLC31A1 mRNA CTD PMID:19371625 zidovudine multiple interactions ISO RGD:735683 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SLC31A1 mRNA CTD PMID:15784690 zinc acetate increases expression ISO RGD:735683 6480464 Zinc Acetate results in increased expression of SLC31A1 mRNA CTD PMID:24132751 zinc atom multiple interactions EXP 6480464 Zinc inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662 zinc(0) multiple interactions EXP 6480464 Zinc inhibits the reaction [SLC31A1 protein results in increased import of Copper] CTD PMID:23123662